Senti Biosciences issues $2M convertible notes, secures $2.5M equity commitment from Celadon affiliate

Senti Biosciences, Inc.

Issued $2.0M aggregate principal Senior Secured Convertible Notes to NSG BioInnovation Fund on Sept 3, 2026.
Notes mature Nov 23, 2026, repayable at 200% of principal; 12% default interest rate applies upon event of default.
Entered equity commitment letter with Celadon affiliate (CPIF II-9 Limited) to purchase $2.5M common stock at Nasdaq Minimum Price.
Shares to be purchased at closing of merger with Celadon affiliate; contingent value right up to $60M cash tied to SENTI-202 milestones.
Merger and CVR subject to stockholder approval; definitive proxy statement to be mailed after filing with SEC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.